Canaan on Twitter
Canaan on LinkedIn
© Copyright 2019 Canaan |
Latest for Nocion
Julie Grant: Announcing Nocion Therapeutics, a novel approach to neurogenic inflammation
Today, Canaan proudly introduces Nocion Therapeutics, a Series A neurogenic inflammation and analgesic company discovering and developing novel pharmaceutical treatments for various indications including pain, cough and itch.
Business Insider: Nocion raises $27M to make a new kind of painkiller as the race to replace opioids heats up
As America grapples with a deadly opioid epidemic, there's a desperate need for better, non-addictive painkillers. Using science out of Harvard and...
FierceBiotech: Nocion launches with $27M and 'charged drugs' to selectively target pain
STAT News: How one company, Nocion, thinks unraveling cough can provide a new way to treat pain